Recombinant Human NPM1 Protein，His

NPM1 (Nucleophosmin 1) is a highly conserved nucleolus-associated protein that plays crucial roles in ribosome biogenesis, cell growth, and genomic stability. Its involvement in cancer, particularly acute myeloid leukemia (AML), has garnered significant attention, as mutations in the NPM1 gene are frequently observed in patients, leading to altered protein function and contributing to leukemogenesis. The most common mutation, NPM1c, results in the aberrant cytoplasmic localization of the protein, disrupting its normal nuclear functions. This altered localization is associated with poor prognosis, making NPM1 a critical biomarker for AML. Understanding the structural properties and functional mechanisms of NPM1 is essential for developing targeted therapies. The study of recombinant NPM1 proteins provides insights into the molecular pathways by which NPM1 mutations drive cancer development. Researchers have utilized various expression systems to produce recombinant NPM1 proteins, facilitating the exploration of their biochemical properties, interactions with other cellular components, and the effects of specific mutations. This research is vital not only for elucidating the pathophysiological roles of NPM1 in cancer but also for devising potential therapeutic strategies aimed at restoring normal NPM1 function or targeting its aberrant pathways in cancer treatment. Overall, NPM1 represents a significant focus in cancer research, bridging the gap between molecular biology and clinical applications in oncology.